Why do men lose hair

Content on WhatAnswers is provided "as is" for informational purposes. While we strive for accuracy, we make no guarantees. Content is AI-assisted and should not be used as professional advice.

Last updated: April 8, 2026

Quick Answer: Male pattern baldness, or androgenetic alopecia, affects approximately 50% of men by age 50, with onset typically beginning in the 20s or 30s. It's primarily caused by genetic sensitivity to dihydrotestosterone (DHT), which shrinks hair follicles over time. Other factors include aging, hormonal changes, and medical conditions like thyroid disorders. Treatments like minoxidil (FDA-approved in 1988) and finasteride (FDA-approved in 1997) can slow hair loss, but results vary.

Key Facts

Approximately 50% of men experience male pattern baldness by age 50
Onset typically begins in the 20s or 30s for most affected men
Genetic sensitivity to DHT (dihydrotestosterone) is the primary cause in 80-90% of cases
Minoxidil was FDA-approved for hair loss treatment in 1988
Finasteride was FDA-approved for male pattern baldness in 1997

Overview

Male pattern baldness, scientifically known as androgenetic alopecia, represents the most common form of hair loss in men, affecting millions worldwide. Historical records trace concerns about hair loss back to ancient civilizations, with Egyptian medical texts from 1550 BCE describing remedies for baldness. The condition follows a predictable pattern first documented by Dr. James Hamilton in 1951, who established the Norwood-Hamilton scale that classifies seven stages of hair loss progression. This scale remains the standard clinical tool for assessing male pattern baldness severity. Modern understanding emerged in the 20th century when researchers identified the role of androgens, particularly DHT, in hair follicle miniaturization. The condition affects all ethnic groups but shows varying prevalence rates, with Caucasian men experiencing the highest incidence at approximately 50% by age 50, compared to about 40% in Asian men and 25% in African men by the same age.

How It Works

Male pattern baldness operates through a biological process called follicular miniaturization, where genetically susceptible hair follicles gradually shrink over multiple growth cycles. The mechanism begins when testosterone converts to dihydrotestosterone (DHT) via the enzyme 5-alpha-reductase. In genetically predisposed individuals, hair follicles in specific scalp regions (typically the frontal and crown areas) possess increased sensitivity to DHT. This sensitivity triggers a shortened anagen (growth) phase and prolonged telogen (resting) phase in the hair cycle. Over time, affected follicles produce progressively thinner, shorter hairs until they eventually cease producing visible hair altogether. The process follows a characteristic pattern: hairline recession at the temples (creating an 'M' shape), thinning at the crown, and eventual merging of these balding areas. Unlike temporary hair loss conditions, this process is permanent without intervention because the miniaturized follicles lose their ability to regenerate normal hair shafts.

Why It Matters

Hair loss significantly impacts men's psychological well-being and social perceptions, with studies showing that 75% of affected men report decreased self-esteem. The global hair loss treatment market reached $2.5 billion in 2020, reflecting substantial economic impact. Beyond cosmetics, pattern baldness serves as a visible marker for certain health risks; research indicates men with vertex baldness have a 32% increased risk of coronary artery disease. The condition also drives medical innovation, spurring developments in hair transplantation techniques (perfected in the 1990s) and emerging therapies like platelet-rich plasma treatments. Understanding male pattern baldness provides insights into broader biological processes of aging and hormone sensitivity that affect various bodily systems beyond just hair follicles.